• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

H&Q Life Sciences Investors

+ Add to Watchlist

HQL:US

20.4600 USD 0.4300 2.06%

As of 20:04:04 ET on 04/17/2014.

Snapshot for H&Q Life Sciences Investors (HQL)

Open: 20.8000 High - Low: 20.9900 - 20.4600 Primary Exchange: New York
Volume: 98,303 52-Week Range: 16.1700 - 25.0000 Beta vs NBI: 0.7857

ETF Chart for HQL

No chart data available.
  • HQL:US 20.4600
  • 1D
  • 1M
  • 1Y
20.8900
Interactive HQL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQL

H&Q Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth.

Inception Date: 1992-05-08 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQL

NAV (on 2014-04-17) 20.2900
Assets (M) (on 2014-04-17) 310.1870
Shares out (M) 15.29
Market Cap (M) 312.78
% Premium 0.84
Average 52-Week % Premium -1.6937
Fund Leveraged N

Dividends for HQL

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-02-27) 0.4200
Dividend Yield (ttm) 7.38%

Performance for HQL

1-Month -12.49% 1-Year +23.08%
3-Month -3.13% 3-Year +29.50%
Year To Date +1.80% 5-Year +30.21%
Expense Ratio 1.47

Top Fund Holdings for HQL

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 464,770 34,927,466 10.909%
Celgene Corp 156,955 26,519,117 8.282%
Regeneron Pharmaceuticals Inc 81,959 22,558,395 7.045%
Biogen Idec Inc 59,788 16,725,693 5.224%
Alexion Pharmaceuticals Inc 111,924 14,892,607 4.651%
Amgen Inc 125,374 14,312,696 4.470%
Incyte Corp Ltd 227,088 11,497,466 3.591%
Vertex Pharmaceuticals Inc 153,029 11,370,055 3.551%
Perrigo Co PLC 66,228 10,163,349 3.174%
iShares Nasdaq Biotechnology E 38,280 8,691,857 2.715%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil